Phenotypes and phosphatidylinositol glycan-class A gene abnormalities during cell differentiation and maturation from precursor cells to mature granulocytes in patients with paroxysmal nocturnal hemoglobinuria

Blood

Volumn 100, Issue 10, 2002, Pages 3812-3818

  Kai, Tatsuyuki ^a,b   Shichishima, Tsutomu ^a,b   Noji, Hideyoshi ^a,b   Yamamoto, Tetsuo ^a,b   Okamoto, Masatoshi ^a,b   Ikeda, Kazuhiko ^a,b   Maruyama, Yukio ^a,b  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^b NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CD59 ANTIGEN; DNA; GLYCAN; GLYCOSYLPHOSPHATIDYLINOSITOL; NUCLEOTIDE; PHOSPHATIDYLINOSITOL;

ADULT; AGED; ARTICLE; CASE REPORT; CELL DIFFERENTIATION; CELL MATURATION; CELL SELECTION; FEMALE; FLOW CYTOMETRY; GENE; GENE MUTATION; GRANULOCYTE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; MALE; NUCLEOTIDE SEQUENCE; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STEM CELL;

EID: 0037111663     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V100.10.3812     Document Type: Article

References (46)

1. Rosse WF, Parker CJ. Paroxysmal nocturnal haemoglobinuria. Clin Haematol. 1985;14:105-125.
2. Young NS. The problem of clonality in aplastic anemia: Dr Dameshek's riddle, restated. Blood. 1992;79:1385-1392.
3. Rosse WF, Dacie JV. Immune lysis of normal human and paroxysmal nocturnal hemoglobinuria (PNH) red blood cells, I: The sensitivity of PNH red cells to lysis by complement and specific antibody. J Clin Invest. 1966;45:736-748.
4. Nicholson-Weller A, Burge J, Fearon DT, Weller PF, Austen KF. Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system. J Immunol. 1982;129:184-189.
5. Sugita Y, Nakano Y, Tomita M. Isolation from human erythrocytes of a new membrane protein which inhibits the formation of complement transmembrane channels. J Biochem. 1988;104:633-637.
6. Takeda J, Miyata T, Kawagoe K, et al. Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria. Cell. 1993;73:703-711.
7. Nicholson-Weller A, March JP, Rosenfeld SI, Austen KF. Affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria are deficient in the complement regulatory protein, decay accelerating factor. Proc Natl Acad Sci U S A. 1983;80:5066-5070.
8. Shichishima T, Terasawa T, Hashimoto C, Ohto H, Uchida T, Maruyama Y. Heterogeneous expression of decay accelerating factor and CD59/membrane attack complex inhibition factor on paroxysmal nocturnal haemoglobinuria (PNH) erythrocytes. Br J Haematol. 1991;78:545-550.
9. Shichishima T, Terasawa T, Saitoh Y, Hashimoto C, Ohto H, Maruyama Y. Diagnosis of paroxysmal nocturnal haemoglobinuria by phenotypic analysis of erythrocytes using two-colour flow cytometry with monoclonal antibodies to DAF and CD59/MACIF. Br J Haematol. 1993;85:378-386.
10. Rosse WF, Hoffman S, Campbell M, Borowitz M, Moore JO, Parker CJ. The erythrocytes in paroxysmal nocturnal haemoglobinuria of intermediate sensitivity to complement lysis. Br J Haematol. 1991;79:99-107.
11. Hall SE, Rosse WF. The use of monoclonal antibodies and flow cytometry in the diagnosis of paroxysmal nocturnal hemoglobinuria. Blood. 1996;87:5332-5340.
12. Boccuni P, Vecchio LD, Noto RB, Rotoli B. Glycosyl phosphatidylinositol (GPI)-anchored molecules and the pathogenesis of paroxysmal nocturnal hemoglobinuria. Oncol Hematol. 2000;33:25-43.
13. Maciejewski JP, Young NS, Yu M, Anderson SM, Sloand EM. Analysis of the expression of glycosylphosphatidylinositol anchored proteins on platelets from patients with paroxysmal nocturnal hemoglobinuria. Thromb Res. 1996;83:433-447.
14. Terstappen LW, Nguyen M, Huang S, Lazarus HM, Medof ME. Defective and normal haematopoietic stem cells in paroxysmal nocturnal haemoglobinuria. Br J Haematol. 1993;84:504-514.
15. Johnson RJ, Rawstron AC, Richards S, Morgan GJ, Norfolk DR, Hillmen SO. Circulating primitive stem cells in paroxysmal nocturnal hemoglobinuria (PNH) are predominantly normal in phenotype but granulocyte colony-stimulating factor treatment mobilizes mainly PNH stem cells. Blood. 1998;91:4504-4508.
16. Tumen J, Kline LB, Fay JW, et al. Complement sensitivity of paroxysmal nocturnal hemoglobinuria bone marrow cells. Blood. 1980;55:1040-1046.
17. Rotoli B, Robledo R, Luzzatto L. Decreased number of circulating BFU-Es in paroxysmal nocturnal hemoglobinuria. Blood. 1982;60:157-159.
18. Dessypris EN, Clark DA, McKee LC Jr, Krantz SB. Increased sensitivity to complement or erythroid and myeloid progenitors in paroxysmal nocturnal hemoglobinuria. N Engl J Med. 1983;309:690-693.
19. Moore JG, Humphries RK, Frank MM, Young N. Characterization of the hematopoietic defect in paroxysmal nocturnal hemoglobinuria. Exp Hematol. 1986;14:222-229.
20. Dessypris EN, Gleaton JH, Clark DA. Increased sensitivity to complement of megakaryocyte progenitors in paroxysmal nocturnal haemoglobinuria. Br J Haematol. 1988;69:305-309.
21. Shichishima T, Terasawa T, Uchida T, Kariyone S. Complement sensitivity of erythroblasts and erythropoietic precursors in paroxysmal nocturnal haemoglobinuria (PNH). Br J Haematol. 1989;72:578-583.
22. Maciejewski JP, Sloand EM, Sato T, Anderson S, Young NS. Impaired hematopoiesis in paroxysmal nocturnal hemoglobinuria/aplastic anemia is not associated with a selective proliferative defect in the glycosylphosphatidylinositol-anchored protein-deficient clone. Blood. 1997;89:1173-1181.
23. Young NS, Maciejewski JP. Genetic and environmental effects in paroxysmal nocturnal hemoglobinuria: This little PIG-A goes "Why? Why? Why?." J Clin Invest. 2000;106:637-641.
24. Nishimura J, Smith CA, Phillips KL, Ware RE, Rosse WF. Paroxysmal nocturnal hemoglobinuria: Molecular pathogenesis and therapeutic approaches. Hematopathol Mol Hematol. 1998;11:119-146.
25. Ostendorf T, Nischan C, Schubert J, et al. Heterogeneous PIG-A mutations in different cell lineages in paroxysmal nocturnal hemoglobinuria. Blood. 1995;85:1640-1646.
26. Pramoonjago P, Pakdeesuwan K, Siripanyaphinyo U, Chinprasertsuk S, Kinoshita T, Wanachiwanawin W. Genotypic, immunophenotypic and clinical features of Thai patients with paroxysmal nocturnal haemoglobinuria. Br J Haematol. 1999;105:497-504.
27. Yamada N, Miyata T, Maeda K, Kitani T, Takeda J, Kinoshita T. Somatic mutations of the PIG-A gene found in Japanese patients with paroxysmal nocturnal hemoglobinuria. Blood. 1995;85:885-892.
28. Nafa K, Mason PJ, Hillmen P, Luzzatto L, Bessler M. Mutations in the PIG-A gene causing paroxysmal nocturnal hemoglobinuria are mainly of the frameshift type. Blood. 1995;86:4650-4655.
29. Endo M, Ware RE, Vreeke TM, et al. Molecular basis of the heterogeneity of expression of glycosyl phosphatidylinositol anchored proteins in paroxysmal nocturnal hemoglobinuria. Blood. 1996;87:2546-2557.
30. Nishimura J, Inoue N, Wada H, et al. A patient with paroxysmal nocturnal hemoglobinuria bearing four independent PIG-A mutant clones. Blood. 1997;89:3470-3476.
31. Rosti V. The molecular basis of paroxysmal nocturnal hemoglobinuria. Haematologica. 2000;85:82-87.
32. Bessler M, Mason PJ, Hillmen P, Luzzatto L. Mutations in the PIG-A gene causing partial deficiency of GPI-linked surface proteins (PNH II) in patients with paroxysmal nocturnal haemoglobinuria. Br J Haematol. 1994;87:863-866.
33. Rollinson S, Richards S, Norfolk D, Bibi K, Morgan G, Hillmen P. Both paroxysmal nocturnal hemoglobinuria (PNH) type II cells and PNH type III cells can arise from different point mutations involving the same codon of the PIG-A gene. Blood. 1997;89:3069-3071.
34. Noji H, Shichishima T, Saitoh Y, et al. The distribution of PIG-A gene abnormalities in paroxysmal nocturnal hemoglobinuria granulocytes and cultured erythroblasts. Exp Hematol. 2001;29:391-400.
35. Shichishima T, Saitoh Y, Terasawa T, Ogawa K, Maruyama Y. Relationship between the phenotypes of circulating erythrocytes and cultured erythroblasts in paroxysmal nocturnal hemoglobinuria. Blood. 1997;90:435-443.
36. + cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering. J Hematother. 1996;5:213-226.
37. Ware RE, Rosse WF, Howard TA. Mutations within the Piga gene in patients with paroxysmal nocturnal hemoglobinuria. Blood. 1994;83:2418-2422.
38. Iida Y, Takeda J, Miyata T, et al. Characterization of genomic PIG-A gene: A gene for glycosylphosphatidylinositol-anchor biosynthesis and paroxysmal nocturnal hemoglobinuda. Blood. 1994;83:3126-3131.
39. Engelke DR, Hoener PA, Collins FS. Direct sequencing of enzymatically amplified human genomic DNA. Proc Natl Acad Sci U S A. 1988;85:544-548.
40. McMahon G, Davis E, Wogan GN. Characterization of c-Ki-ras oncogene alleles by direct sequencing of enzymatically amplified DNA from carcinogen-induced tumors. Proc Natl Acad Sci U S A. 1987;84:4974-4978.
41. Rabessandratana H, Toutant J-P, Reggio H, Vidal M. Decay accelerating factor (CD55) and membrane inhibitor of reactive lysis (CD59) are released within exsomes during in vitro maturation of reticulocytes. Blood. 1998;91:2573-2580.
42. Luzzatto L, Bessler M. The dual pathogenesis of paroxysmal nocturnal hemoglobinuria. Curr Opin Hematol. 1996;3:101-110.
43. Kawaguchi K, Wada H, Mori A, Takemoto Y, Kakishita E, Kanamaru A. Detection of GPI-anchored protein-deficient cells in patients with aplastic anaemia and evidence for clonal expansion during the clinical course. Br J Haematol. 1999;105:80-84.
44. Kanamaru A, Okuda K, Ueda E, Kitani T, Kinoshita T, Nagai K. Different distribution of decayaccelerating factor on hematopoietic progenitors from normal individuals and patients with paroxysmal nocturnal hemoglobinuria. Blood. 1988;72:507-511.
45. Okuda K, Kanamaru A, Ueda E, et al. Expression of decay-accelerating factor on hematopoietic progenitors and their progeny cells grown in cultures with fractionated bone marrow cells from normal individuals and patients with paroxysmal nocturnal hemoglobinuria. Exp Hematol. 1990;18:1132-1136.
46. + stem cells in primary paroxysmal nocturnal hemoglobinuria. J Clin Invest. 2000;106:689-696.